Research paper
View All-
Antonia Maria S. Müller
CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement
-
Antonia Maria S. Müller
CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement
-
Adrian Schmidt
Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
-
Sara De Dosso
A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line
-
Sara De Dosso
A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line